MRS 2578

MRS 2578

Catalog Number:
L002370332APE
Mfr. No.:
APE-B2167
Price:
$180
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          MRS 2578 is a potent and insurmountable antagonist of P2Y6 nucleotide receptor with IC50 value of 37nM [1].
          MRS 2578, a diisothiocyanate derivative, is an insurmountable antagonist of P2Y6 receptors which are associated with vasoconstriction. Thus MRS 2578 is expected to be used in treatment of vasospasm. In 1321N1 human astrocytes expressing P2Y6 receptors, MRS 2578 inhibits the UDP-induced accumulation of inositol phosphates in a dose-dependent manner. MRS 2578 also inhibits the rat P2Y6 receptor activation with IC50 value of 98nM. These effects are selective. MRS 2578 has no effect on the UTP-induced responses of cells expressing human P2Y2 or P2Y4 receptors. It also has no effect on the 2-MeSADP-induced responses of cells expressing the P2Y1 receptor. Moreover, since the UDP-induced activation of P2Y6 receptor can protect the cells from apoptosis induced by TNFα, MRS 2578 completely blocks the protection of cells [1].

          [1] Mamedova L K, Joshi B V, Gao Z G, et al. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors[J]. Biochemical pharmacology, 2004, 67(9): 1763-1770.

      • Properties
        • Categories
          P2Y6 receptor antagonist, potent and selective
          Alternative Name
          1-(3-isothiocyanatophenyl)-3-[4-[(3-isothiocyanatophenyl)carbamothioylamino]butyl]thiourea
          CAS Number
          711019-86-2
          Molecular Formula
          C20H20N6S4
          Molecular Weight
          472.68
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥19.75 mg/mL in DMSO
          Storage
          Store at -20°C
          SMILES
          C1=CC(=CC(=C1)NC(=S)NCCCCNC(=S)NC2=CC=CC(=C2)N=C=S)N=C=S

          * For Research Use Only

      • Reference
        • 1. Wen RX, Shen H, et al. "P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis." CNS Neurosci Ther. 2020;26(4):416-429. PMID:32154670

    We Also Recommend

    IPA-3

    $190

    NMS-873

    $276

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.